Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Down syndrome critical region 10 (DSCR10) is a non-protein coding RNA gene mapped to chromosome 21, specifically to the Down syndrome critical region implicated in trisomy 21 (Down syndrome)[1][5]. While its proximity to key protein-coding genes and its inclusion within "highly restricted Down syndrome critical regions" has made it a subject of interest, DSCR10 itself does not encode a protein nor has any direct molecular function or disease association been established[1][5][2]. There is currently no evidence to support its role as a receptor, enzyme, transcription factor, or drug target. Its functional significance, if any, is unknown, and ongoing research is required to determine whether its transcript has any regulatory or biological impact[2][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Down syndrome critical region 10 (DSCR10).